CELL TISSUE GROUP WAS CELEBRATED AMONG THE ELITE “30 TECHNO DREAMS”
This notable event, held during the MTDC Technology Conference & Exhibition (MTCE) 2023 at the Royale Chulan Kuala Lumpur, was ceremoniously officiated by the Minister of Science, Technology and Innovation, Mr. Chang Lih Kang, underscoring the event's importance and Cell Tissue's status within the MTDC's 30-year history.
LEARN MORE
LOOKING FOR MORE INFORMATION?
We welcome inquiries and feedback. For further information or specific questions, please contact us directly.
LEARN MORE
Previous
Next

Transforming Medicine, Empowering Lives

Holistic Solutions for untapped medical needs

REVOLUTIONIZING TISSUE ENGINEERING REGENERATIVE MEDICINE

1999 – 2024

With a research-driven approach, Cell Tissue Group develops transformative solutions in Tissue Engineering and Regenerative Medicine. We explore the potential of cellular technologies to unlock new treatments and improve outcomes for a wide range of diseases, addressing both existing and emerging medical challenges.

EXPLORE THE NEXT ERA of MEDICAL ADVANCEMENT

Cell Tissue Group‘s cutting-edge research and scientific advancements in Tissue Engineering and Regenerative Medicine are driving the next generation of medical treatments. Our approaches enable the body to heal and repair itself, offering alternatives to conventional treatments with minimal side effects, supported by the latest cellular technologies.

WHY CHOOSE CELL TISSUE GROUP?

Cell Tissue Group is the preferred choice for advanced solutions in Tissue Engineering and Regenerative Medicine. Our excellence in research, commitment to innovation, and personalized approach, all within cGMP compliance, make us a trusted partner for professionals and individuals seeking breakthroughs in medical, aesthetic, and research applications.

INTRODUCTION TO

Our Innovative Technologies

At Cell Tissue Group, we are pushing the boundaries of Tissue Engineering and Regenerative Medicine with our pioneering technologies.

Our research focuses on four key areas:

Stem Cell Research

Advancing healthcare by repairing damaged tissues through cutting-edge stem cell therapy.

Cell-Based Immuno-Research
(NK Cell Program)

Empowering the immune system to target diseases such as cancer, using precise cellular technologies.

Secretome & Exosome Research

Harnessing cellular communication for improved wellness and anti-aging benefits.

Tissue Engineering research

Innovating solutions to regenerate tissues and expedite healing processes, utilizing advanced cellular techniques.

Our continuous research efforts are dedicated to advancing medical innovation in Tissue Engineering and Regenerative Medicine, under cGMP standards.

OUR RESEARCH PROGRAMS

STEM CELL RESEARCH​

Cell Tissue Group leverages Mesenchymal Stem Cells (MSCs) to enhance tissue repair and overall wellness. This is a core aspect of our Tissue Engineering and Regenerative Medicine initiatives, all within cGMP guidelines.

CELL-BASED IMMUNO-RESEARCH

Utilizing the natural power of Natural Killer (NK) Cells, we aim to target and eliminate cancer cells while preserving healthy tissue, boosting the immune response, and reducing side effects. This research is integral to our Regenerative Medicine efforts.

SECRETOME & EXOSOME RESEARCH

Our research in Secretome and Exosome technology focuses on enhancing intercellular communication. This helps to control inflammation, support the immune system, and promote anti-aging, all within the larger scope of Tissue Engineering and Regenerative Medicine, adhering to cGMP standards.

TISSUE ENGINEERING research

At the heart of Cell Tissue Group's mission is Tissue Engineering, where we develop and apply techniques to regenerate and repair tissues. This research is critical in addressing the global organ shortage and accelerating the healing process.

Meet the Visionary Innovator Behind Cell Tissue Group

DATUK DR. KHAIRUL IDZWAN BAHARIN D.P.S.M, DABRM, MBBS
DATUK DR. KHAIRUL IDZWAN BAHARIN D.P.S.M, DABRM, MBBS

FOUNDER, CELL TISSUE GROUP

DATUK DR. KHAIRUL IDZWAN BAHARIN D.P.S.M, DABRM, MBBS

FOUNDER, CELL TISSUE GROUP

MBBS (IMU), American Academy of Aesthetic Medicine (AAAM), Diploma in American Board of Regenerative Medicine (DABRM), Certificate in Clinical Wound Care (CCWC), SKM3 Aesthetic Cosmetology

Datuk Dr. Khairul Idzwan Baharin or friendly known as Datuk Dr. Idzu is a medical doctor, biomedical innovator, certified aesthetician, and aspiring medical technopreneur. He served as the CEO and later the Managing Director of Cell Tissue Group, a UKM spin-off specializing in Tissue Engineering and Regenerative Medicine, with a focus on skin loss solutions. His passion for this field stems from witnessing patients’ pain due to skin loss or non-healing wounds during his medical practice.

Beyond his medical role, Datuk Dr. Idzu innovated aesthetic medicine and wound management technologies while expanding Cell Tissue Group. His achievements include the MEGAGist Award and recognition as a “Transformer of Excellence” by the U.S. Department of State under President Obama’s administration. He also received the “Leadership Excellence in Stem Cells & Tissue Engineering” award in the Global Leadership Awards 2019. Driven by his dedication, he strives to establish Malaysia’s leading Tissue Engineering Firm and Southeast Asia’s hub for a brighter medical future.

AS SEEN ON SEEN ON

As Seen On

PARTNERS PARTNERS

RECOGNITIONS RECOGNITIONS